This lncRNA through modulation of S100A1/Hippo (29) and miR-363-5p/S100A1 pathways (30) can participate in the pathogenesis of breast cancer and nasopharyngeal carcinoma, respectively (Table 6). Here, S100A1 is linked to breast carcinoma.